AQR Capital Management LLC Buys 400,833 Shares of Owens & Minor, Inc. $OMI

Key Points

• AQR Capital Management LLC increased its stake in Owens & Minor, acquiring an additional 400,833 shares for a total of 634,914 shares, marking a 171.2% increase in ownership.
• Major shareholder Coliseum Capital Management purchased 492,852 shares at an average price of $5.31 per share, increasing their stake by 3.91%.
• Owens & Minor reported $0.26 earnings per share, missing estimates of $0.27, and has set a FY 2025 EPS guidance of 1.020-1.070.

AQR Capital Management LLC increased its stake in shares of Owens & Minor, Inc. (NYSE:OMI - Free Report) by 171.2% in the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 634,914 shares of the company's stock after buying an additional 400,833 shares during the period. AQR Capital Management LLC owned about 0.82% of Owens & Minor worth $5,733,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the stock. Vanguard Group Inc. increased its holdings in Owens & Minor by 2.7% during the first quarter. Vanguard Group Inc. now owns 9,156,759 shares of the company's stock worth $82,686,000 after buying an additional 241,003 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in Owens & Minor by 19.4% during the first quarter. Charles Schwab Investment Management Inc. now owns 2,752,960 shares of the company's stock worth $24,859,000 after buying an additional 447,917 shares during the last quarter. Invesco Ltd. increased its holdings in Owens & Minor by 19.9% during the first quarter. Invesco Ltd. now owns 1,716,895 shares of the company's stock worth $15,504,000 after buying an additional 285,060 shares during the last quarter. Northern Trust Corp increased its holdings in Owens & Minor by 13.7% during the fourth quarter. Northern Trust Corp now owns 968,101 shares of the company's stock worth $12,653,000 after buying an additional 116,754 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. increased its holdings in Owens & Minor by 133.1% during the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 703,050 shares of the company's stock worth $6,349,000 after buying an additional 401,472 shares during the last quarter. Hedge funds and other institutional investors own 98.04% of the company's stock.

Insider Buying and Selling

In other news, major shareholder Coliseum Capital Management, L purchased 492,852 shares of the stock in a transaction that occurred on Thursday, August 14th. The stock was bought at an average cost of $5.31 per share, for a total transaction of $2,617,044.12. Following the acquisition, the insider directly owned 13,100,807 shares of the company's stock, valued at $69,565,285.17. This represents a 3.91% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In the last three months, insiders have acquired 1,537,852 shares of company stock worth $8,099,544. Corporate insiders own 3.69% of the company's stock.

Owens & Minor Price Performance

OMI stock opened at $5.30 on Friday. The stock has a market cap of $408.99 million, a PE ratio of -0.34 and a beta of 1.03. The company has a debt-to-equity ratio of 3.32, a current ratio of 0.86 and a quick ratio of 0.83. Owens & Minor, Inc. has a one year low of $4.56 and a one year high of $16.47. The firm has a 50 day simple moving average of $6.46 and a two-hundred day simple moving average of $7.40.

Owens & Minor (NYSE:OMI - Get Free Report) last announced its quarterly earnings data on Monday, August 11th. The company reported $0.26 earnings per share for the quarter, missing analysts' consensus estimates of $0.27 by ($0.01). The business had revenue of $681.90 million during the quarter, compared to the consensus estimate of $2.73 billion. Owens & Minor had a positive return on equity of 26.59% and a negative net margin of 13.78%.The company's revenue was up 3.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.36 earnings per share. Owens & Minor has set its FY 2025 guidance at 1.020-1.070 EPS. On average, analysts predict that Owens & Minor, Inc. will post 1.51 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on OMI. JPMorgan Chase & Co. decreased their price objective on shares of Owens & Minor from $7.00 to $6.00 and set an "underweight" rating for the company in a report on Wednesday, August 27th. Zacks Research downgraded shares of Owens & Minor from a "hold" rating to a "strong sell" rating in a research note on Tuesday, September 2nd. UBS Group set a $7.00 target price on shares of Owens & Minor in a research note on Wednesday, August 13th. Robert W. Baird reduced their target price on shares of Owens & Minor from $10.00 to $7.00 and set an "outperform" rating for the company in a research note on Tuesday, August 12th. Finally, Bank of America reduced their target price on shares of Owens & Minor from $7.50 to $4.75 and set an "underperform" rating for the company in a research note on Tuesday, August 12th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, one has issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $7.63.

About Owens & Minor

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.